Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study.
Saved in:
| Title: | Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study. |
|---|---|
| Authors: | Dbaibo GS; Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research On Bacterial Pathogens, American University of Beirut, Beirut, Lebanon.; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Balik I; Infectious Disease and Clinical Microbiology Department, Ankara Universitesi Medical School, Ankara, Türkiye., Akdemir İ; Infectious Disease and Clinical Microbiology Department, Ankara Universitesi Medical School, Ankara, Türkiye., Buzgan T; Ankara Bilkent City Hospital, Department of Infectious Diseases and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara, Türkiye., Guner R; Ankara Bilkent City Hospital, Department of Infectious Diseases and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara, Türkiye., Boutros CF; Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research On Bacterial Pathogens, American University of Beirut, Beirut, Lebanon., Damaj S; Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research On Bacterial Pathogens, American University of Beirut, Beirut, Lebanon., Zein ZE; Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research On Bacterial Pathogens, American University of Beirut, Beirut, Lebanon.; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Merhi S; Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research On Bacterial Pathogens, American University of Beirut, Beirut, Lebanon., Faour K; Department of Pediatrics, CMU Health, Saginaw, MI, USA., Tfaily N; Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research On Bacterial Pathogens, American University of Beirut, Beirut, Lebanon., Khafaja S; Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research On Bacterial Pathogens, American University of Beirut, Beirut, Lebanon.; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Dogu A; Medical Affairs Department, Sanofi Vaccines, Level 3, One JLT Building, Jumeirah Lake Towers, P.O. Box 53899, Dubai, UAE. Alp.Dogu@sanofi.com., Ceyhan M; Hacettepe University School of Medicine, Ankara, Türkiye. |
| Source: | Infectious diseases and therapy [Infect Dis Ther] 2026 Mar; Vol. 15 (3), pp. 769-785. Date of Electronic Publication: 2026 Jan 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
